Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

被引：60

作者：

Boumber, Yanis ^{[1
,2
,3
]}

机构：

[1] Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[2] Fox Chase Canc Ctr, Dept Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[3] Kazan Fed Univ, Insititute Fundamental Med & Biol, Kazan, Russia

来源：

JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 08期

基金：

俄罗斯基础研究基金会;

关键词：

NIVOLUMAB PLUS IPILIMUMAB; TOPOTECAN; BLOCKADE;

D O I：

10.21037/jtd.2018.07.120

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：4689 / 4693

页数：5

共 24 条

[1] Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial [J].

Antonia, Scott J. ;

Lopez-Martin, Jose A. ;

Bendell, Johanna ;

Ott, Patrick A. ;

Taylor, Matthew ;

Eder, Joseph Paul ;

Jaeger, Dirk ;

Pietanza, M. Catherine ;

Le, Dung T. ;

de Braud, Filippo ;

Morse, Michael A. ;

Ascierto, Paolo A. ;

Horn, Leora ;

Amin, Asim ;

Pillai, Rathi N. ;

Evans, Jeffry ;

Chau, Ian ;

Bono, Petri ;

Atmaca, Akin ;

Sharma, Padmanee ;

Harbison, Christopher T. ;

Lin, Chen-Sheng ;

Christensen, Olaf ;

Calvo, Emiliano .

LANCET ONCOLOGY, 2016, 17 (07) :883-895

[2] Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: A pooled analysis of topotecan second-line trials [J].

Ardizzoni, Andrea ;

Tiseo, Marcello ;

Boni, Luca .

EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) :2211-2218

[3] Recent Advances in Immunotherapy in Metastatic NSCLC [J].

Bansal, Pranshu ;

Osman, Diaa ;

Gan, Gregory N. ;

Simon, George R. ;

Boumber, Yanis .

FRONTIERS IN ONCOLOGY, 2016, 6

[4]

Broderick JM, FDA GRANTS NIVOLUMAB

[5] First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer [J].

Carbone, D. P. ;

Reck, M. ;

Paz-Ares, L. ;

Creelan, B. ;

Horn, L. ;

Steins, M. ;

Felip, E. ;

van den Heuvel, M. M. ;

Ciuleanu, T. -E. ;

Badin, F. ;

Ready, N. ;

Hiltermann, T. J. N. ;

Nair, S. ;

Juergens, R. ;

Peters, S. ;

Minenza, E. ;

Wrangle, J. M. ;

Rodriguez-Abreu, D. ;

Borghaei, H. ;

Blumenschein, G. R. ;

Villaruz, L. C. ;

Havel, L. ;

Krejci, J. ;

Corral Jaime, J. ;

Chang, H. ;

Geese, W. J. ;

Bhagavatheeswaran, P. ;

Chen, A. C. ;

Socinski, M. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25) :2415-2426

[6] Neoadjuvant PD-1 Blockade in Resectable Lung Cancer [J].

Forde, P. M. ;

Chaft, J. E. ;

Smith, K. N. ;

Anagnostou, V. ;

Cottrell, T. R. ;

Hellmann, M. D. ;

Zahurak, M. ;

Yang, S. C. ;

Jones, D. R. ;

Broderick, S. ;

Battafarano, R. J. ;

Velez, M. J. ;

Rekhtman, N. ;

Olah, Z. ;

Naidoo, J. ;

Marrone, K. A. ;

Verde, F. ;

Guo, H. ;

Zhang, J. ;

Caushi, J. X. ;

Chan, H. Y. ;

Sidhom, J. -W. ;

Scharpf, R. B. ;

White, J. ;

Gabrielson, E. ;

Wang, H. ;

Rosner, G. L. ;

Rusch, V. ;

Wolchok, J. D. ;

Merghoub, T. ;

Taube, J. M. ;

Velculescu, V. E. ;

Topalian, S. L. ;

Brahmer, J. R. ;

Pardoll, D. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (21) :1976-1986

[7] Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden [J].

Hellmann, M. D. ;

Ciuleanu, T. -E. ;

Pluzanski, A. ;

Lee, J. S. ;

Otterson, G. A. ;

Audigier-Valette, C. ;

Minenza, E. ;

Linardou, H. ;

Burgers, S. ;

Salman, P. ;

Borghaei, H. ;

Ramalingam, S. S. ;

Brahmer, J. ;

Reck, M. ;

O'Byrne, K. J. ;

Geese, W. J. ;

Green, G. ;

Chang, H. ;

Szustakowski, J. ;

Bhagavatheeswaran, P. ;

Healey, D. ;

Fu, Y. ;

Nathan, F. ;

Paz-Ares, L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2093-2104

[8] Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer [J].

Hellmann, Matthew D. ;

Callahan, Margaret K. ;

Awad, Mark M. ;

Calvo, Emiliano ;

Ascierto, Paolo A. ;

Atmaca, Akin ;

Rizvi, Naiyer A. ;

Hirsch, Fred R. ;

Selvaggi, Giovanni ;

Szustakowski, Joseph D. ;

Sasson, Ariella ;

Golhar, Ryan ;

Vitazka, Patrik ;

Chang, Han ;

Geese, William J. ;

Antonia, Scott J. .

CANCER CELL, 2018, 33 (05) :853-+

[9] Nivolumab (nivo) ± ipilimumab (ipi) in advanced small-cell lung cancer (SCLC): First report of a randomized expansion cohort from CheckMate 032. [J].

Hellmann, Matthew David ;

Ott, Patrick Alexander ;

Zugazagoitia, Jon ;

Ready, Neal E. ;

Hann, Christine L. ;

De Braud, Filippo G. ;

Antonia, Scott Joseph ;

Ascierto, Paolo Antonio ;

Moreno, Victor ;

Atmaca, Akin ;

Salvagni, Stefania ;

Taylor, Matthew H. ;

Amin, Asim ;

Camidge, D. Ross ;

Horn, Leora ;

Calvo, Emiliano ;

Cai, Weiguo ;

Fairchild, Justin P. ;

Callahan, Margaret K. ;

Spigel, David R. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[10] Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients [J].

Horita, Nobuyuki ;

Yamamoto, Masaki ;

Sato, Takashi ;

Tsukahara, Toshinori ;

Nagakura, Hideyuki ;

Tashiro, Ken ;

Shibata, Yuji ;

Watanabe, Hiroki ;

Nagai, Kenjiro ;

Inoue, Miyo ;

Nakashima, Kentaro ;

Ushio, Ryota ;

Shinkai, Masaharu ;

Kudo, Makoto ;

Kaneko, Takeshi .

SCIENTIFIC REPORTS, 2015, 5

← 1 2 3 →